+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

  • PDF Icon

    Report

  • 180 Pages
  • December 2024
  • Region: Global
  • BCC Research
  • ID: 4703998
The Global Bioprocess Optimization and Digital Bio-manufacturing Market was valued at USD 24.3 Billion in 2024, and is expected to reach USD 39.6 Billion by 2029, rising at a CAGR of 10.20%.

The report provides a comprehensive analysis of the bioprocess optimization and digital biomanufacturing market in a global context, including market forecasts and sales through the year 2029. Segmentation based on technology type includes manufacturing technologies (chromatography-based separation and purification, filtration, bioreactors, centrifugation), analytical and process control technologies (spectrophotometry, automation and industrial process control technologies, analytical chromatography, sensors and probes), and software (Industrial control and automation software, bioprocess optimization and data analytics software).

Segmentation based on application includes biomanufacturing process automation and control, flexible manufacturing, bioprocess optimization and process analytics, and others. By molecule type the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins and peptides, and cell and gene therapies. The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

The report discusses the critical issues impacting the adoption of digital biomanufacturing in pharmaceuticals, as well as emerging trends in digital biomanufacturing technologies. It also features new developments and new product launches in the global market. The report provides comprehensive profiles of market players in the industry. The report also covers mergers and acquisitions and any other collaborations or partnerships that occurred during the evaluation period of this report and which are expected to shape the industry.

Report Includes

  • 69 data tables and 61 additional tables
  • Analyses of trends in the global market for bioprocess optimization and digital bio-manufacturing, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
  • Estimates of the market size and revenue growth prospects of the global market, along with a market share analysis by technology, application, drug molecule type and region
  • Facts and figures pertaining to the market dynamics, technical advances, regulations and the impact of macroeconomic factors
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • Analysis of patents, emerging trends, and new developments
  • Analysis of the industry structure, including companies’ market shares, strategic alliances, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and ESG scores and practices of leading companies
  • Profiles of the market leaders, including Agilent Technologies Inc., Thermo Fisher Scientific Inc., Danaher Corp., and Sartorius AG.

Table of Contents

Chapter 1 Introduction
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview
  • Overview
  • Technology Background
  • Biologics Manufacturing Process
  • Upstream Processing
  • Cell Harvesting and Clarification
  • Downstream Processing
  • Bioprocess Optimization
  • Industry 4.0 - Digital Biomanufacturing
Chapter 3 Market Dynamics
  • Global Market Dynamics
  • Market Drivers
  • Growing Aging Population
  • Increasing Prevalence of Chronic Diseases
  • Unprecedented Rise in Demand for Biopharmaceuticals
  • Growing Number of Product Launches
  • Increasing Number of Contract Manufacturing Organizations (CMOs)
  • Market Restraints
  • Lack of Skilled Labor
  • High Cost of Equipment
  • Unharmonized Smart Manufacturing Standards
  • Market Opportunities
  • Favorable Government Programs
  • Advances in Sensor Technology
  • Process Analytical Technology Initiatives
  • Market Challenges
  • Technical Issues and the Threat of Cyberattacks
  • Regulatory Landscape
  • Good Automation Manufacturing Practices (GAMP)
  • Instrumentation, Systems, and Automation (ISA) Society-88 and 95 Standards
Chapter 4 Emerging Technologies and Developments
  • Emerging Trends and Technologies
  • Continuous Bioprocessing
  • Continuous Cell Retention Technologies
  • Continuous Chromatography
  • Single-Use Technologies
Chapter 5 Market Segmentation Analysis
  • Key Market Trends
  • Segmentation Breakdown
  • Market Analysis by Technology
  • Manufacturing Technologies
  • Analytical and Process Control Technologies
  • Software
  • Market Analysis by Application
  • Biomanufacturing Process Automation and Control
  • Flexible Manufacturing
  • Bioprocess Optimization and Process Analytics
  • Other Applications
  • Market Analysis by Molecule Type
  • Monoclonal Antibodies (mAbs)
  • Therapeutic Proteins and Peptides
  • Vaccines
  • Cell and Gene Therapies
  • Geographic Breakdown
  • Market Analysis by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 6 Competitive Intelligence
  • Ranking of Leading Players
  • Key Strategies Adopted by Players
  • Collaborations and Partnerships
  • Expansion
  • Acquisitions
  • New Product Launches
Chapter 7 Sustainability in the Bioprocess Optimization and Digital Biomanufacturing Market: An ESG Perspective
  • Introduction to ESG
  • ESG Practices in the Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Companies’ ESG Risk Ratings
  • Concluding Remarks
Chapter 8 Appendix
  • Methodology
  • Information Sources
ReferencesAbbreviations
Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • AGILITECH
  • BIO-RAD LABORATORIES INC.
  • BRUKER
  • CLEAN BIOLOGICS
  • DANAHER CORP.
  • EMERSON ELECTRIC CO.
  • EPPENDORF SE
  • KORBER AG
  • MERCK KGAA
  • SARTORIUS AG
  • SHIMADZU CORP.
  • THERMO FISHER SCIENTIFIC INC.
  • UNIVERCELLS TECHNOLOGIES
  • WATERS CORP.
List of Tables
Summary Table A: Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Summary Table B: Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 1: List of Biologics Produced in E. coli
Table 2: List of Biologics Produced in Mammalian Cells
Table 3: Number and Distribution of Persons Aged 60+, by Region, 2019 and 2050
Table 4: Global Cancer Incidence and Mortality Cases, by WHO Region, 2022
Table 5: Medicine Regulators and Biosimilar Approvals, 2024
Table 6: List of Regulatory Guidelines Related to Biopharmaceutical Manufacturing, 2024
Table 7: Examples of Continuous Processing Developments
Table 8: Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 9: Global Market for Manufacturing Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Type, Through 2029
Table 10: Global Market for Manufacturing Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 11: Global Market for Chromatography-based Separation and Purification Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 12: Global Market for Filtration Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 13: Global Market for Bioreactor Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 14: Global Market for Centrifugation Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 15: Global Market for Analytical and Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Type, Through 2029
Table 16: Global Market for Analytical and Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 17: Global Market for Spectrophotometry in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 18: Global Market for Automation and Industrial Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region Through 2029
Table 19: Global Market for Analytical Chromatography in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 20: Global Market for Sensors and Probes in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 21: Global Market for Software in Bioprocess Optimization and Digital Biomanufacturing, by Type, Through 2029
Table 22: Global Market for Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 23: Global Market for Industrial Control and Automation Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 24: Global Market for Bioprocess Optimization and Data Analytics Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 25: Global Market for Other Software Types in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 26: Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 27: Global Market for Biomanufacturing Process Automation and Control Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 28: Global Market for Flexible Manufacturing Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 29: Global Market for Bioprocess Optimization and Process Analytics Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 30: Global Market for Other Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 31: Global Market for Bioprocess Optimization and Digital Biomanufacturing , by Molecule Type, Through 2029
Table 32: Global Market of Monoclonal Antibodies in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 33: Global Market for Therapeutic Proteins and Peptides in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 34: Global Market for Vaccines in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 35: Global Market for Cell and Gene Therapies in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 36: Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 37: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 38: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, Through 2029
Table 39: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, Through 2029
Table 40: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, Through 2029
Table 41: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 42: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, Through 2029
Table 43: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 44: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, Through 2029
Table 45: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, Through 2029
Table 46: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, Through 2029
Table 47: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 48: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, Through 2029
Table 49: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 50: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, Through 2029
Table 51: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, Through 2029
Table 52: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, Through 2029
Table 53: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 54: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, Through 2029
Table 55: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 56: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, Through 2029
Table 57: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, Through 2029
Table 58: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of for Software, Through 2029
Table 59: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 60: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, Through 2029
Table 61: Ranking of Leading Players in the Bioprocess Optimization and Digital Biomanufacturing Market, 2023
Table 62: Collaborations and Partnerships: Bioprocess Optimization and Digital Biomanufacturing Market, 2021-2024
Table 63: Expansion: Bioprocess Optimization and Digital Biomanufacturing Market, 2020-2024
Table 64: Acquisitions: Bioprocess Optimization and Digital Biomanufacturing Market, 2020-2024
Table 65: New Product Launches: Bioprocess Optimization and Digital Biomanufacturing Market, 2022-2024
Table 66: Key Focus Areas in ESG Metrics
Table 67: Environmental Performance Initiatives in the Bioprocess Optimization and Digital Biomanufacturing Market
Table 68: Social Performance Initiatives in the Bioprocess Optimization and Digital Biomanufacturing Market
Table 69: Governance Performance Initiatives in the Bioprocess Optimization and Digital Biomanufacturing Market
Table 70: ESG Rankings for Key Players in the Bioprocess Optimization and Digital Biomanufacturing Market, 2024*
Table 71: Abbreviations Used in this Report
Table 72: Agilent Technologies Inc.: Company Snapshot
Table 73: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 74: Agilent Technologies Inc.: Product & Services Portfolio
Table 75: Agilent Technologies Inc.: News/Key Developments, 2022-2024
Table 76: Agilitech: Company Snapshot
Table 77: Agilitech: Product Portfolio
Table 78: Agilitech: News/Key Developments, 2022 and 2024
Table 79: Bio-Rad Laboratories Inc.: Company Snapshot
Table 80: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 81: Bio-Rad Laboratories Inc.: Product Portfolio
Table 82: Bio-Rad Laboratories Inc.: News/Key Developments,2022
Table 83: Bruker: Company Snapshot
Table 84: Bruker: Financial Performance, FY 2022 and 2023
Table 85: Bruker: Product Portfolio
Table 86: Bruker: News/Key Developments, 2022 and 2023
Table 87: Clean Biologics: Company Snapshot
Table 88: Clean Biologics: Product & Services Portfolio
Table 89: Clean Biologics: News/Key Developments, 2021-2023
Table 90: Danaher Corp.: Company Snapshot
Table 91: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 92: Danaher Corp.: Product Portfolio
Table 93: Danaher Corp.: News/Key Developments, 2023
Table 94: Emerson Electric Co.: Company Snapshot
Table 95: Emerson Electric Co.: Financial Performance, FY 2022 and 2023
Table 96: Emerson Electric Co.: Product Portfolio
Table 97: Emerson Electric Co.: News/Key Developments, 2022-2024
Table 98: Eppendorf SE: Company Snapshot
Table 99: Eppendorf SE: Financial Performance, FY 2022 and 2023
Table 100: Eppendorf SE: Product Portfolio
Table 101: Eppendorf SE: News/Key Developments, 2022-2024
Table 102: Korber AG: Company Snapshot
Table 103: Korber AG: Financial Performance, FY 2022 and 2023
Table 104: Korber AG: Product Portfolio
Table 105: Korber AG: News/Key Developments, 2024
Table 106: Merck KGaA: Company Snapshot
Table 107: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 108: Merck KGaA: Product Portfolio
Table 109: Merck KGaA: News/Key Developments, 2024
Table 110: Sartorius AG: Company Snapshot
Table 111: Sartorius AG: Financial Performance, FY 2022 and 2023
Table 112: Sartorius AG: Product Portfolio
Table 113: Sartorius AG: News/Key Developments, 2021-2024
Table 114: Shimadzu Corp.: Company Snapshot
Table 115: Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 116: Shimadzu Corp.: Product Portfolio
Table 117: Shimadzu Corp.: News/Key Developments, 2024
Table 118: Thermo Fisher Scientific Inc.: Company Snapshot
Table 119: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 120: Thermo Fisher Scientific Inc.: Product Portfolio
Table 121: Thermo Fisher Scientific Inc.: News/Key Developments, 2020-2022
Table 122: Univercells Technologies: Company Snapshot
Table 123: Univercells Technologies: Product Portfolio
Table 124: Univercells Technologies: News/Key Developments, 2024
Table 125: Waters Corp.: Company Snapshot
Table 126: Waters Corp.: Financial Performance, FY 2022 and 2023
Table 127: Waters Corp.: Product Portfolio
Table 128: Waters Corp.: News/Key Developments, 2021-2023
List of Figures
Summary Figure A: Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Summary Figure B: Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 1: A Typical Biopharmaceutical Manufacturing Process
Figure 2: Market Dynamics for Bioprocess Optimization and Digital Biomanufacturing
Figure 3: Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2024
Figure 4: Global Market for Manufacturing Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Type, 2021-2029
Figure 5: Global Market for Manufacturing Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 6: Global Market for Chromatography-based Separation and Purification Technology in Bioprocess Optimization and Digital Biomanufacturing , by Region, 2021-2029
Figure 7: Global Market for Filtration Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 8: Global Market for Bioreactor Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 9: Global Market for Centrifugation Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 10: Global Market for Analytical and Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Type, 2021-2029
Figure 11: Global Market for Analytical and Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 12: Global Market for Spectrophotometry in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 13: Global Market for Automation and Industrial Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 14: Global Market for Analytical Chromatography in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 15: Global Market for Sensors and Probes in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 16: Global Market for Software in Bioprocess Optimization and Digital Biomanufacturing, by Type, 2021-2029
Figure 17: Global Market for Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 18: Global Market for Industrial Control and Automation Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 19: Global Market for Bioprocess Optimization and Data Analytics Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 20: Global Market for Other Software Types in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 21: Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2024
Figure 22: Global Market for Biomanufacturing Process Automation and Control Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 23: Global Market for Flexible Manufacturing Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 24: Global Market for Bioprocess Optimization and Process Analytics Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 25: Global Market for Other Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 26: Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2024
Figure 27: Global Market of Monoclonal Antibodies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 28: Global Market for Therapeutic Proteins and Peptides in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 29: Global Market for Vaccines in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 30: Global Market for Cell and Gene Therapies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 31: Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Region, 2024
Figure 32: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Figure 33: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, 2021-2029
Figure 34: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, 2021-2029
Figure 35: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, 2021-2029
Figure 36: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2021-2029
Figure 37: North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2021-2029
Figure 38: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Figure 39: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, 2021-2029
Figure 40: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, 2021-2029
Figure 41: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, 2021-2029
Figure 42: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2021-2029
Figure 43: European Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2021-2029
Figure 44: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Figure 45: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, 2021-2029
Figure 46: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, 2021-2029
Figure 47: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, 2021-2029
Figure 48: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2021-2029
Figure 49: Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2021-2029
Figure 50: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Figure 51: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, 2021-2029
Figure 52: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, 2021-2029
Figure 53: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, 2021-2029
Figure 54: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2021-2029
Figure 55: RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2021-2029
Figure 56: Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Key Strategies Adopted, 2020 to 2024
Figure 57: How a Strong ESG Proposition Benefits Businesses
Figure 58: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 59: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 60: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 61: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 62: Bruker: Revenue Share, by Business Unit, FY 2023
Figure 63: Bruker: Revenue Share, by Country/Region, FY 2023
Figure 64: Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 65: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 66: Emerson Electric Co.: Revenue Share, by Business Unit, FY 2023
Figure 67: Emerson Electric Co.: Revenue Share, by Country/Region, FY 2023
Figure 68: Eppendorf SE: Revenue Share, by Business Unit, FY 2023
Figure 69: Eppendorf SE: Revenue Share, by Country/Region, FY 2023
Figure 70: Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 71: Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 72: Sartorius AG: Revenue Share, by Business Unit, FY 2023
Figure 73: Sartorius AG: Revenue Share, by Country/Region, FY 2023
Figure 74: Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 75: Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 76: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 77: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Figure 78: Waters Corp.: Revenue Share, by Business Unit, FY 2023
Figure 79: Waters Corp.: Revenue Share, by Country/Region, FY 2023

Samples

Loading
LOADING...

Executive Summary

Over the last few years, the biopharmaceuticals market has witnessed tremendous growth. Innovation in the types of biological drug candidates has been remarkable. The expiration of patents of many blockbuster drugs has led to the rise of the biosimilars market, too. As a result, the biologic drug manufacturers who had been practicing age-old business models and traditional methods of biomanufacturing are now faced with numerous challenges. Improvement is required in process productivity in the form of production processes becoming faster and more cost-effective, and the processes also need to be GMP (good manufacturing practices)-compliant. The U.S. Food and Drug Administration (FDA) launched the Process Analytical Technology (PAT) initiative in 2004 with an aim to imbibe quality in production processes by way of monitoring and controlling the processes in real-time. Sophisticated techniques of analysis, single-use technologies, and continuous processing are becoming popular as methods that can bring about efficiencies in the biomanufacturing processes, as well as save time and investments.

The biopharmaceutical market is rapidly adopting the “smart technologies” that define the industrial revolution 4.0 (or Industry 4.0). Though industrial control systems and automation have been part of the manufacturing platforms for quite some time, Industry 4.0 has brought about a new revolution by integrating the information technology and operational technology. The industrial internet of things (IIoT) streamlines the entire business operations of a company. Biopharmaceutical manufacturers can obtain several benefits by implementing IIoT in manufacturing, as it can drive process efficiencies; provide agility to the manufacturing and entire supply chain; provide tracking, visibility, and predictive maintenance; as well as save time in obtaining regulatory compliance.

The highly regulated nature of the biopharmaceutical industry, complemented by the complexity of biological production processes has delayed the entry of Industry 4.0 in this sector. Moreover, the need to transform legacy systems and obtain fresh validations for new ones or those processes requiring any modifications are additional obstacles. Nevertheless, the long-term merits offered by smart manufacturing and digitization in bioprocessing are driving this market.

There is heightened activity in the mergers and acquisitions among technology-driven companies, particularly single-use technologies and information technology companies. An increased number of collaborations and partnerships between private players, industry-government and industry-academic organizations are also fostering innovation and aiding the adoption of modern technologies for biomanufacturing. Another factor driving the bioprocess optimization and digital biomanufacturing market is the significant growth seen in contract manufacturing organizations, specifically in emerging countries. Countries in Asia-Pacific, including China, India, Singapore, and Korea, are witnessing rapid
growth due to rising demands for automation and novel innovative technologies for improved manufacturing processes. The market forces of innovation and the need to implement PAT (Process Analytical Technology) in the bio/pharmaceutical processes are also driving this market.

Companies Mentioned

  • AGILENT TECHNOLOGIES INC.
  • AGILITECH
  • BIO-RAD LABORATORIES INC.
  • BRUKER
  • CLEAN BIOLOGICS
  • DANAHER CORP.
  • EMERSON ELECTRIC CO.
  • EPPENDORF SE
  • KORBER AG
  • MERCK KGAA
  • SARTORIUS AG
  • SHIMADZU CORP.
  • THERMO FISHER SCIENTIFIC INC.
  • UNIVERCELLS TECHNOLOGIES
  • WATERS CORP.

Table Information